J591 177LU
As of the edition of 20 October 2026, J591 177LU is a drug: stopped in 2020; acts on FOLH1.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Stopped, 2020
- Kind
- Unknown
- Registered trials
- 5, 1 stopped early
- Disease areas
- Cancer; Urinary and reproductive; Digestive system; Hormones; Lungs and airways; Pregnancy and women's health
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| FOLH1 | Glutamate carboxypeptidase 2 | Q04609 |
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 1 | 2 | 2 | 0 | 0 |
| Phase 2 | 3 | 1 | 1 | 1 |
| All trials | 5 |